Table ST2 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma

<p>Table ST2: Summary of the clinical data corresponding to the primary cell cultures used in this publication</p>

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Ossia M. Eichhoff (14964145) (author)
Weitere Verfasser:	Corinne I. Stoffel (14964148) (author), Jan Käsler (14964151) (author), Luzia Briker (14964154) (author), Patrick Turko (14964157) (author), Gergely Karsai (14964160) (author), Nina Zila (14964163) (author), Verena Paulitschke (14964166) (author), Phil F. Cheng (14940278) (author), Alexander Leitner (14964169) (author), Andrea Bileck (14964172) (author), Nicola Zamboni (14964175) (author), Anja Irmisch (14964178) (author), Zsolt Balazs (14964181) (author), Aizhan Tastanova (14964184) (author), Susana Pascoal (14964187) (author), Pål Johansen (14964190) (author), Rebekka Wegmann (6698010) (author), Julien Mena (14964193) (author), Alaa Othman (14964196) (author), Vasanthi S. Viswanathan (14964199) (author), Judith Wenzina (14964202) (author), Andrea Aloia (14964205) (author), Annalisa Saltari (14964208) (author), Andreas Dzung (14964211) (author), Michael Krauthammer (14964214) (author), Stuart L. Schreiber (14964217) (author), Thorsten Hornemann (14964220) (author), Martin Distel (14964223) (author), Berend Snijder (14964226) (author), Reinhard Dummer (14850772) (author), Mitchell P. Levesque (14964229) (author)
Veröffentlicht:	2025
Schlagworte:	Cancer Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Drug Resistance Reversal of drug resistance Metabolism Metabolomics Skin Cancers Melanoma Tumor Heterogeneity
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

_version_	1849927638870654976
author	Ossia M. Eichhoff (14964145)
author2	Corinne I. Stoffel (14964148) Jan Käsler (14964151) Luzia Briker (14964154) Patrick Turko (14964157) Gergely Karsai (14964160) Nina Zila (14964163) Verena Paulitschke (14964166) Phil F. Cheng (14940278) Alexander Leitner (14964169) Andrea Bileck (14964172) Nicola Zamboni (14964175) Anja Irmisch (14964178) Zsolt Balazs (14964181) Aizhan Tastanova (14964184) Susana Pascoal (14964187) Pål Johansen (14964190) Rebekka Wegmann (6698010) Julien Mena (14964193) Alaa Othman (14964196) Vasanthi S. Viswanathan (14964199) Judith Wenzina (14964202) Andrea Aloia (14964205) Annalisa Saltari (14964208) Andreas Dzung (14964211) Michael Krauthammer (14964214) Stuart L. Schreiber (14964217) Thorsten Hornemann (14964220) Martin Distel (14964223) Berend Snijder (14964226) Reinhard Dummer (14850772) Mitchell P. Levesque (14964229)
author2_role	author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author
author_facet	Ossia M. Eichhoff (14964145) Corinne I. Stoffel (14964148) Jan Käsler (14964151) Luzia Briker (14964154) Patrick Turko (14964157) Gergely Karsai (14964160) Nina Zila (14964163) Verena Paulitschke (14964166) Phil F. Cheng (14940278) Alexander Leitner (14964169) Andrea Bileck (14964172) Nicola Zamboni (14964175) Anja Irmisch (14964178) Zsolt Balazs (14964181) Aizhan Tastanova (14964184) Susana Pascoal (14964187) Pål Johansen (14964190) Rebekka Wegmann (6698010) Julien Mena (14964193) Alaa Othman (14964196) Vasanthi S. Viswanathan (14964199) Judith Wenzina (14964202) Andrea Aloia (14964205) Annalisa Saltari (14964208) Andreas Dzung (14964211) Michael Krauthammer (14964214) Stuart L. Schreiber (14964217) Thorsten Hornemann (14964220) Martin Distel (14964223) Berend Snijder (14964226) Reinhard Dummer (14850772) Mitchell P. Levesque (14964229)
author_role	author
dc.creator.none.fl_str_mv	Ossia M. Eichhoff (14964145) Corinne I. Stoffel (14964148) Jan Käsler (14964151) Luzia Briker (14964154) Patrick Turko (14964157) Gergely Karsai (14964160) Nina Zila (14964163) Verena Paulitschke (14964166) Phil F. Cheng (14940278) Alexander Leitner (14964169) Andrea Bileck (14964172) Nicola Zamboni (14964175) Anja Irmisch (14964178) Zsolt Balazs (14964181) Aizhan Tastanova (14964184) Susana Pascoal (14964187) Pål Johansen (14964190) Rebekka Wegmann (6698010) Julien Mena (14964193) Alaa Othman (14964196) Vasanthi S. Viswanathan (14964199) Judith Wenzina (14964202) Andrea Aloia (14964205) Annalisa Saltari (14964208) Andreas Dzung (14964211) Michael Krauthammer (14964214) Stuart L. Schreiber (14964217) Thorsten Hornemann (14964220) Martin Distel (14964223) Berend Snijder (14964226) Reinhard Dummer (14850772) Mitchell P. Levesque (14964229)
dc.date.none.fl_str_mv	2025-11-24T23:01:39Z
dc.identifier.none.fl_str_mv	10.1158/0008-5472.30699973
dc.relation.none.fl_str_mv	https://figshare.com/articles/dataset/Table_ST2_from_ROS_Induction_Targets_Persister_Cancer_Cells_with_Low_Metabolic_Activity_in_NRAS-Mutated_Melanoma/30699973
dc.rights.none.fl_str_mv	CC BY info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv	Cancer Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Drug Resistance Reversal of drug resistance Metabolism Metabolomics Skin Cancers Melanoma Tumor Heterogeneity
dc.title.none.fl_str_mv	Table ST2 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
dc.type.none.fl_str_mv	Dataset info:eu-repo/semantics/publishedVersion dataset
description	<p>Table ST2: Summary of the clinical data corresponding to the primary cell cultures used in this publication</p>
eu_rights_str_mv	openAccess
id	Manara_45c3eb318d91d3cc6e801da6aa95d59a
identifier_str_mv	10.1158/0008-5472.30699973
network_acronym_str	Manara
network_name_str	ManaraRepo
oai_identifier_str	oai:figshare.com:article/30699973
publishDate	2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv	CC BY
spelling	Table ST2 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated MelanomaOssia M. Eichhoff (14964145)Corinne I. Stoffel (14964148)Jan Käsler (14964151)Luzia Briker (14964154)Patrick Turko (14964157)Gergely Karsai (14964160)Nina Zila (14964163)Verena Paulitschke (14964166)Phil F. Cheng (14940278)Alexander Leitner (14964169)Andrea Bileck (14964172)Nicola Zamboni (14964175)Anja Irmisch (14964178)Zsolt Balazs (14964181)Aizhan Tastanova (14964184)Susana Pascoal (14964187)Pål Johansen (14964190)Rebekka Wegmann (6698010)Julien Mena (14964193)Alaa Othman (14964196)Vasanthi S. Viswanathan (14964199)Judith Wenzina (14964202)Andrea Aloia (14964205)Annalisa Saltari (14964208)Andreas Dzung (14964211)Michael Krauthammer (14964214)Stuart L. Schreiber (14964217)Thorsten Hornemann (14964220)Martin Distel (14964223)Berend Snijder (14964226)Reinhard Dummer (14850772)Mitchell P. Levesque (14964229)CancerTumor BiologyMolecular and Cellular BiologyTherapeutic Research and DevelopmentDrug ResistanceReversal of drug resistanceMetabolismMetabolomicsSkin CancersMelanomaTumor Heterogeneity<p>Table ST2: Summary of the clinical data corresponding to the primary cell cultures used in this publication</p>2025-11-24T23:01:39ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/0008-5472.30699973https://figshare.com/articles/dataset/Table_ST2_from_ROS_Induction_Targets_Persister_Cancer_Cells_with_Low_Metabolic_Activity_in_NRAS-Mutated_Melanoma/30699973CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/306999732025-11-24T23:01:39Z
spellingShingle	Table ST2 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma Ossia M. Eichhoff (14964145) Cancer Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Drug Resistance Reversal of drug resistance Metabolism Metabolomics Skin Cancers Melanoma Tumor Heterogeneity
status_str	publishedVersion
title	Table ST2 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
title_full	Table ST2 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
title_fullStr	Table ST2 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
title_full_unstemmed	Table ST2 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
title_short	Table ST2 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
title_sort	Table ST2 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
topic	Cancer Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Drug Resistance Reversal of drug resistance Metabolism Metabolomics Skin Cancers Melanoma Tumor Heterogeneity

Table ST2 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma

Ähnliche Einträge